MedTrace Logo

Clinical Trials

NCT05432791 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
74 participants

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2023-03-30
Completion:
2024-08-13
Conditions
  • Locally Advanced Uterine Corpus Leiomyosarcoma
  • Metastatic Uterine Corpus Leiomyosarcoma
  • Stage III Uterine Corpus Leiomyosarcoma AJCC v8
  • Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
  • Unresectable Uterine Corpus Leiomyosarcoma
Interventions
  • PROCEDURE
  • DRUG
Results Available
NCT05365685 | COMPLETED | NA
18 participants

Energy Turnover and Appetite

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2022-08-27
Completion:
2022-10-29
Conditions
  • Obesity
Interventions
  • BEHAVIORAL
No Results Yet
NCT05317585 | RECRUITING | NA
180 participants

Continuous Glucose Monitor Use in Pregnancy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2024-05-23
Completion:
2026-12-31
Conditions
  • Type 2 Diabetes Treated With Insulin
  • Pregnancy, High Risk
Interventions
  • DEVICE
No Results Yet
NCT05285358 | RECRUITING | PHASE1
12 participants

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2022-09-19
Completion:
2028-10-11
Conditions
  • Distal Bile Duct Adenocarcinoma
  • Gallbladder Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Metastatic Malignant Neoplasm in the Peritoneum
  • Stage IV Distal Bile Duct Cancer AJCC v8
  • Stage IV Intrahepatic Bile Duct Cancer AJCC v8
  • Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
  • Stage IVB Gallbladder Cancer AJCC v8
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05072483 | RECRUITING
155 participants

Natural History Study of CADASIL

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-03
Start Date:
2022-04-18
Completion:
2034-06-01
Conditions
  • Cardiovascular Disease
  • Arterial Stiffness
  • Germline Mutation in the NOTCH 3 Gene
  • Pathogenesis of CADASIL
  • Clinical Phenotype of CADASIL
Interventions
  • DEVICE
No Results Yet
NCT04924075 | RECRUITING | PHASE2
355 participants

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2021-08-12
Completion:
2029-12-27
Conditions
  • Pheochromocytoma/Paraganglioma
  • Pancreatic Neuroendocrine Tumor
  • Von Hippel-Lindau Disease
  • Advanced Gastrointestinal Stromal Tumor
  • HIF-2α Mutated Cancers
Interventions
  • DRUG
No Results Yet
NCT04876781 | RECRUITING
200 participants

Korean Post-marketing Surveillance for Xeljanz XR

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-03
Start Date:
2022-01-12
Completion:
2026-09-22
Conditions
  • Active Moderate to Severe Rheumatoid Arthritis
  • Active Ankylosing Spondylitis
  • Active Psoriatic Arthritis
Interventions
  • DRUG
No Results Yet
NCT04753970 | RECRUITING | PHASE1/PHASE2
100 participants

Retina is a Marker for Cerebrovascular Heath

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2021-02-09
Completion:
2030-06-30
Conditions
  • Cerebral Small Vessel Diseases
  • Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
  • Cerebral Microbleeding
  • Sporadic White Matter Disease
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page